Fineline Cube

Follow:
14467 Articles
CompanyDeals

Eli Lilly Completes Acquisition of Dice Therapeutics for $2.0 Billion

CompanyDrug

Sichuan Kelun-Biotech’s SKB264 Achieves Primary Endpoint in Phase III TNBC Study

CompanyDrug

Huadong Medicine’s HDM3001, a Biosimilar to Stelara, Accepted for Review by NMPA

CompanyDeals

Cascade Pharmaceuticals Secures RMB140 Million in Financing to Advance FXR Agonist Clinical Trials

CompanyDeals

Migrasome Therapeutics Secures Over RMB100 Million in Angel+ Funding Round

CompanyDrug

CanSino BiologicsLaunches Phase III Trial for DTcP Vaccine in Infants and Young Children

Policy / Regulatory

Hunan HSA Implements Direct BMI Fund Payments for VBP-Winning Drugs and Consumables

Policy / Regulatory

SAMR and Nine Ministries Tighten Regulations on Forums and Conferences in China

CompanyDrug

Cutia Therapeutics’ CU-10201 Enters Priority Review for Acne Treatment in China

CompanyDeals

Huadong Medicine Secures Exclusive Rights to Arcutis’ Daxas in Greater China and South-East Asia

CompanyDeals

Medtronic Partners with APMG to Advance Orthopedic Treatment Services in China

CompanyDeals

Everest Medicines and Shanghai Pharmaceuticals Deepen Partnership for Drug Distribution in China